Related Experiment Videos
Cancer in developing countries: opportunity and challenge
Journal of the National Cancer Institute
|June 2, 1993
Summary
Developing nations face a growing cancer burden despite lower incidence rates. Increased global collaboration in cancer research is crucial for prevention and understanding environmental carcinogenesis.
Area of Science:
- Epidemiology
- Environmental Carcinogenesis
- Global Health
Background:
- Environment and lifestyle significantly influence cancer's geographical distribution.
- Developing countries bear a disproportionate global cancer burden, projected to increase due to demographic and lifestyle shifts.
- Economic constraints and inadequate healthcare infrastructure in developing nations exacerbate cancer control challenges.
Purpose of the Study:
- To highlight the escalating cancer burden in developing countries and the need for enhanced prevention strategies.
- To emphasize the unique research opportunities in developing countries for understanding environmental carcinogenesis.
- To advocate for increased international collaboration to overcome research barriers.
Main Methods:
- Epidemiologic observations on cancer patterns and determinants.
- Analysis of demographic trends, lifestyle changes, and economic factors affecting cancer burden.
- Identification of challenges and opportunities for cancer research in developing nations.
Main Results:
- Developing countries, despite lower incidence, bear over half the global cancer burden, with this proportion expected to rise.
- Economic progress and lifestyle changes (tobacco, diet) contribute to increasing cancer rates in developing nations.
- Significant barriers to cancer research exist in developing countries, including lack of registries and infrastructure.
Conclusions:
- Greater emphasis on cancer prevention is essential in developing countries.
- Developing countries offer unique opportunities to study environmental carcinogenesis mechanisms.
- Expanded international research collaboration is vital to address global cancer challenges and improve outcomes.